Literature DB >> 19680140

Selective deposition of 4-repeat tau in cerebral infarcts.

Kazuaki Ichihara1, Toshiki Uchihara, Ayako Nakamura, Yoshio Suzuki, Tomohiko Mizutani.   

Abstract

The tau deposits found in neurodegenerative diseases are classified based on their isoforms, that is, 3-repeat (3R) tau and 4-repeat (4R) tau. These isoforms are distinguishable using the antibodies RD3 and RD4, respectively, and Gallyas (Gal) and Campbell-Switzer (CS) silver staining methods, respectively. Tau is also deposited in cerebral infarcts. To characterize the tau profile in these lesions, 21 brains from autopsied patients with cerebral infarcts were analyzed using immunohistochemistry with RD3, RD4, and the anti-paired helical filament antibody AT8 and with Gal and CS staining; all of these techniques identify Alzheimer disease-type neurofibrillary tangles. Fluorescence labeling followed by silver staining in mirror-section pairs was also used to compare the staining patterns. Neurons in and around ischemic foci exhibited the 4R-tau epitope until 34 days postinfarction; argyrophilia with Gal staining persisted longer. The 4R-tau/Gal-positive neurons were negative for 3R-tau and AT8 epitopes and lacked fibrillary structures and argyrophilia by CS staining; they are, therefore, distinct from neurons with neurofibrillary tangles. Positivity for 4R tau/Gal and negativity for 3R tau/CS were also seen in astrocytes and microglia around infarcts. Although this staining profile is characteristic of degenerative processes with 4R-tau deposition, lack of AT8 immunoreactivity and of fibrillary structures in neurons, astrocytes, and microglia indicates that selective 4R-tau deposition represents a stage without tau phosphorylation or fibril formation in cerebral infarcts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19680140     DOI: 10.1097/NEN.0b013e3181b56bf4

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  Modifications of tau protein after cerebral ischemia and reperfusion in rats are similar to those occurring in Alzheimer's disease - Hyperphosphorylation and cleavage of 4- and 3-repeat tau.

Authors:  Hiroki Fujii; Tetsuya Takahashi; Tomoya Mukai; Shigeru Tanaka; Naohisa Hosomi; Hirofumi Maruyama; Norio Sakai; Masayasu Matsumoto
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

2.  Classification of diseases with accumulation of Tau protein.

Authors:  Gabor G Kovacs; Bernardino Ghetti; Michel Goedert
Journal:  Neuropathol Appl Neurobiol       Date:  2022-02-09       Impact factor: 6.250

3.  Hypoxia alters expression of zebrafish microtubule-associated protein tau (mapta, maptb) gene transcripts.

Authors:  Seyyed Hani Moussavi Nik; Morgan Newman; Swamynathan Ganesan; Mengqi Chen; Ralph Martins; Giuseppe Verdile; Michael Lardelli
Journal:  BMC Res Notes       Date:  2014-10-31

4.  Tauopathy in basal ganglia involvement is exacerbated in a subset of patients with Alzheimer's disease: The Hisayama study.

Authors:  Hideomi Hamasaki; Hiroyuki Honda; Satoshi O Suzuki; Masahiro Shijo; Tomoyuki Ohara; Yozo Hatabe; Tsuyoshi Okamoto; Toshiharu Ninomiya; Toru Iwaki
Journal:  Alzheimers Dement (Amst)       Date:  2019-06-06

5.  How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity.

Authors:  Momoko Ebashi; Yoshinori Ito; Miho Uematsu; Ayako Nakamura; Katsuiku Hirokawa; Satoshi Kamei; Toshiki Uchihara
Journal:  Acta Neuropathol Commun       Date:  2019-05-06       Impact factor: 7.801

6.  Multimodal 18F-AV-1451 and MRI Findings in Nonfluent Variant of Primary Progressive Aphasia: Possible Insights on Nodal Propagation of Tau Protein Across the Syntactic Network.

Authors:  Belen Pascual; Quentin Funk; Paolo Zanotti-Fregonara; Neha Pal; Elijah Rockers; Meixiang Yu; Bryan Spann; Gustavo C Román; Paul E Schulz; Christof Karmonik; Stanley H Appel; Joseph C Masdeu
Journal:  J Nucl Med       Date:  2019-07-26       Impact factor: 10.057

7.  Visualization of ischemic stroke-related changes on 18F-THK-5351 positron emission tomography.

Authors:  Kuo-Lun Huang; Jung-Lung Hsu; Kun-Ju Lin; Chien-Hung Chang; Yi-Ming Wu; Ting-Yu Chang; Yeu-Jhy Chang; Chi-Hung Liu; Meng-Yang Ho; Shiaw-Pyng Wey; Tzu-Chen Yen; Nobuyuki Okamura; Ing-Tsung Hsiao; Tsong-Hai Lee
Journal:  EJNMMI Res       Date:  2018-07-16       Impact factor: 3.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.